MiR-193a-5p/ERBB2 act as concurrent chemoradiation therapy response indicator of esophageal squamous cell carcinoma

Concurrent chemoradiation therapy (CCRT) is the predominant treatment in esophageal cancer, however resistance to therapy and tumor recurrence are exceedingly common. Elevated ERBB2/Her2 may be at least partially responsible for both the high rates of recurrence and resistance to CCRT. This receptor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Lin, Cheng-Han, Tsai, Chen-Hsun, Yeh, Ching-Tung, Liang, Jui-Lin, Hung, Wan-Chun, Lin, Forn-Chia, Chang, Wei-Lun, Li, Hao-Yi, Yao, Yun-Chin, Hsu, Tai-I, Lee, Yu-Cheng, Wang, Yi-Ching, Sheu, Bor-Shyang, Lai, Wu-Wei, Calkins, Marcus J., Hsiao, Michael, Lu, Pei-Jung
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5129962/
https://ncbi.nlm.nih.gov/pubmed/27203740
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9444
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados